Anti-Human IFNG Therapeutic Antibody (Fontolizumab)

Recombinant monoclonal antibody to IFNG. Fontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease.
Supplier Creative Biolabs
Product # TAB-041
Pricing Inquiry
Host Mouse
Target IFNG
Species Reactivity Human
Type IgG1
Applications IP, IF, FuncS, FC, Neut, ELISA, IHC, Activ
Storage Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.
Feedback